Cambridge Investment Research Advisors, Inc. - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 171 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$234,000
-3.3%
12,0000.0%0.00%
-33.3%
Q1 2018$242,000
+50.3%
12,000
-1.4%
0.00%
+50.0%
Q4 2017$161,00012,1750.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 2,650,000$48,893,0003.10%
Voce Capital Management LLC 110,789$2,044,0002.72%
Palo Alto Investors LP 3,441,233$63,491,0002.67%
FALCON POINT CAPITAL, LLC 839,477$13,180,0001.91%
EII CAPITAL MANAGEMENT, INC. 119,690$2,208,0000.83%
CLARK ESTATES INC/NY 163,300$3,013,0000.50%
IRONWOOD INVESTMENT MANAGEMENT LLC 38,358$708,0000.50%
Jabre Capital Partners S.A. 120,000$2,214,0000.43%
Credit Capital Investments LLC 15,000$277,0000.31%
Alambic Investment Management, L.P. 151,442$2,794,0000.30%
View complete list of AMAG PHARMACEUTICALS INC shareholders